4-Amino-1-N-Fmoc-piperidine hydrochloride, 97.0%, 1g

1-(3-FLUORO-PHENYL)-CYCLOPROPYLAMINE, 95.0%, 250mg

3-Chloro-7H-pyrrolo[2,3-c]pyridazine, 95.0%, 10g

6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-3-carboxylic acid, 1g

4,5,6,7-TETRAHYDRO-1H-INDOLE-2-CARBOXYLIC ACID ETHYL ESTER, 97.0%, 1g

2-Chloro-N-(2-(diethylamino)ethyl)quinoline-4-carboxamide, 95.0%, 100mg

2-Amino-4-bromo-6-fluorobenzothiazole, 95.0%, 5g

Plan PLMi 10x/0.25 infinity corrected IOS objective. Working distance 20.2 mm

2-[(Diphenylmethylene)amino]acetonitrile, 95.0%, 10g

(R)-4-ISOPROPYL-2-(ISOQUINOLIN-1-YL)-4,5-DIHYDROOXAZOLE, 95%, 250mg

2-Amino-3-(benzyloxy)propan-1-ol, 98%, 1g

Atenolol>98.0%(T)10g

3-bromo-1-methyl-1H,4H,7H-pyrazolo[3,4-d]pyrimidin-4-one, 98%, 500mg